Just a moment, the page is loading...
Compassionate Use (Expanded Access) Request Portal

Provision of unlicensed medicines for unmet medical needs

We recognise that there may be instances when it is appropriate for Healthcare Professionals to seek an unapproved medicine or vaccine for treatment use for a patient where no satisfactory alternatives exist. Our policy and programmes may provide an option for providers and patients faced with these challenges.

Provision of unlicensed medicines for unmet medical needs in various places and circumstances may be referred to as single patient use, named patient use, compassionate use, expanded access, special access, managed access, importation of unlicensed medicine, or other names.

Please read our policy on treatment use of unlicensed medicines here

Healthcare Professional requests for compassionate use

If you are a Healthcare Professional and would like to make a request for compassionate use of a GSK investigational medicine, please create a profile and submit a request using the tabs at the top of this page.

Receipt of your request will be acknowledged within 24 hours.

In order to handle your enquiry, we are required to record and maintain the personal information that you have provided to us. This may include your name and contact details. This personal information will be processed solely for the purpose of dealing with your enquiry. More detailed information on the processing of your personal information is available from our Privacy Notice.

Patients themselves cannot make a request for compassionate use and need to contact their Healthcare Professional.

GSK's Compassionate Use

Please click on the link below which will take you to the GSK web site for reporting possible side effects.

To help us verify your identity, a validation code will be sent to you.

Enter code here

- Back to Top -
© 2001-2024 GlaxoSmithKline plc. All rights reserved. Registered in England and Wales No. 3888792.
Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.